7Baggers
 biocardia, inc. (nasdaq:bcda) q3 2025 earnings call transcript  Insider Monkey Fri, 14 Nov 2025 19:48:54 GMT
 BioCardia’s Earnings Call: Progress Amid Financial Challenges  TipRanks Fri, 14 Nov 2025 01:23:20 GMT
 BioCardia (BCDA) Q3 2025 Earnings Call Transcript  The Motley Fool Thu, 13 Nov 2025 17:12:00 GMT
 BioCardia, Inc. Q3 Loss Decreases, Beats Estimates  Nasdaq Thu, 13 Nov 2025 01:27:00 GMT
 BioCardia’s Funding Fuels Progress For Its Heart Therapy  Finimize Thu, 13 Nov 2025 00:01:46 GMT
 Cellular therapy developer BioCardia's Q3 net loss narrows  TradingView Wed, 12 Nov 2025 21:49:20 GMT
 BioCardia, Inc. (BCDA) Q3 FY2025 earnings call transcript  Yahoo Finance Wed, 12 Nov 2025 21:30:00 GMT
 Earnings Outlook For BioCardia  Benzinga Tue, 11 Nov 2025 18:03:22 GMT
 BioCardia enrolls first patient in phase 3 heart failure trial By Investing.com  Investing.com Nigeria Tue, 11 Nov 2025 06:47:58 GMT
 BioCardia enrolls first patient in phase 3 heart failure trial  Investing.com Mon, 10 Nov 2025 14:13:35 GMT
 BioCardia Enrolls First Patient in Phase 3 Trial  TipRanks Mon, 10 Nov 2025 13:35:48 GMT
 biocardia investors await critical quarterly update  AD HOC NEWS Sat, 08 Nov 2025 07:32:04 GMT
 biocardia inc. (bcda) stock price | live quotes & charts | nsc  StocksToTrade Sat, 08 Nov 2025 00:26:00 GMT
 published on: 2025-11-07 01:09:40  newser.com Fri, 07 Nov 2025 07:09:40 GMT
 biocardia sets record date for annual meeting  MSN Sun, 02 Nov 2025 11:30:27 GMT

BioCardia, Inc
(NASDAQ:BCDA) 

BCDA stock logo

BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmo...

Full Time Employees: 20
CEO: Peter Altman  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends